Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Ottawa Marriott Hotel

Oct 18, 2016 8:00 AM - Oct 19, 2016 4:00 PM

100 Kent Street , Ottawa, ON K1P5R7 , CANADA

DIA Annual Canadian Meeting 2016

Explore how innovation can support new initiatives, regulatory processes, research, transparency, engagement, personalized medicine, and use of real-world data in Canada.

Session 5 Track C: Generics and Biosimilars

Session Chair(s)

Loretta  Del Bosco

Loretta Del Bosco

Director, Regulatory Affairs Quality Assurance Operations

AbbVie Corporation, Canada

Gain an overview of generics and biosimilars from a regulator, industry, and industry consultant perspective. The field of generics continues to evolve and Canada is entering into the new era of biosimilars. What are the challenges? What are the opportunities? How are generics and biosimilars different? Hear from subject matter experts on this exciting and sometimes controversial topic.

Speaker(s)

Donald  Elrick, PhD

Speaker

Donald Elrick, PhD

Janssen Inc, Canada

Director Regulatory Affairs, Immunology

Anne  Tomalin, RAC

Policy in the Development of Generics and Biosimilars in Canada

Anne Tomalin, RAC

Tpireg, A Division of Innomar-Strategies Inc., Canada

Agnes  Klein, MD

Speaker

Agnes Klein, MD

Health Canada, Canada

Senior Medical Advisor

Dawn  Culp

Speaker

Dawn Culp

Hikma, United States

VP, Regulatory Affairs

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.